NCT04870034 2023-12-22Binimetinib and Palbociclib Before Surgery for the Treatment of Operable KRAS-Positive Lung, Colorectal, or Pancreatic CancerRoswell Park Cancer InstitutePhase EARLY_PHASE1 Withdrawn